当前位置:首页 - 行情中心 - 方盛制药(603998) - 财务分析 - 现金流量表

方盛制药

(603998)

  

流通市值:43.95亿  总市值:43.95亿
流通股本:4.39亿   总股本:4.39亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,346,475,488.03946,185,261.3470,620,751.891,769,205,435.13
  收到的税费返还848,863.73720,468.85-817,140.02
  收到其他与经营活动有关的现金42,881,744.5335,308,725.3114,475,375.8578,412,698.06
  经营活动现金流入小计1,390,206,096.29982,214,455.46485,096,127.741,848,435,273.21
  购买商品、接受劳务支付的现金180,739,540.85122,280,793.6768,306,411.52345,996,554.54
  支付给职工以及为职工支付的现金215,779,709157,187,706.890,238,992.43279,890,063.37
  支付的各项税费210,819,063.96162,106,594.2880,968,479.2213,791,997.41
  支付其他与经营活动有关的现金355,687,222.71270,774,535.54165,396,191.6624,124,762.43
  经营活动现金流出小计963,025,536.52712,349,630.29404,910,074.751,463,803,377.75
  经营活动产生的现金流量净额427,180,559.77269,864,825.1780,186,052.99384,631,895.46
二、投资活动产生的现金流量:
  收回投资收到的现金738,993,539.26464,946,637.95129,080,000794,744,724.59
  取得投资收益收到的现金1,871,794.62493,717.43138,096.35688,175.22
  处置固定资产、无形资产和其他长期资产收回的现金净额4,786,859.384,244,489.38603,490.12,613,871
  处置子公司及其他营业单位收到的现金净额---24,398,706.26
  收到的其他与投资活动有关的现金14,075,00011,075,0003,000,00076,789,051
  投资活动现金流入小计759,727,193.26480,759,844.76132,821,586.45899,234,528.07
  购建固定资产、无形资产和其他长期资产支付的现金64,781,736.5737,694,760.8322,141,722.18102,516,244.11
  投资支付的现金767,580,000519,080,000164,080,000715,000,000
  支付其他与投资活动有关的现金10,564,993.510,564,993.5--
  投资活动现金流出小计842,926,730.07567,339,754.33186,221,722.18817,516,244.11
  投资活动产生的现金流量净额-83,199,536.81-86,579,909.57-53,400,135.7381,718,283.96
三、筹资活动产生的现金流量:
  吸收投资收到的现金25,198,267.8825,198,267.8811,065,37522,620,336
  其中:子公司吸收少数股东投资收到的现金25,198,267.8825,198,267.8811,065,37522,620,336
  取得借款收到的现金273,000,000269,000,000170,000,000363,400,000
  筹资活动现金流入小计298,198,267.88294,198,267.88181,065,375386,020,336
  偿还债务支付的现金482,350,000369,350,000195,000,000638,550,000
  分配股利、利润或偿付利息支付的现金231,970,631.42143,025,353.7568,358,906.36200,276,402.18
  其中:子公司支付给少数股东的股利、利润7,006,5007,006,500-7,006,500
  支付其他与筹资活动有关的现金5,465,071.73,986,985.891,607,723.8241,304,984.39
  筹资活动现金流出小计719,785,703.12516,362,339.64264,966,630.18880,131,386.57
  筹资活动产生的现金流量净额-421,587,435.24-222,164,071.76-83,901,255.18-494,111,050.57
四、汇率变动对现金及现金等价物的影响-75,423.87-64,825.9-23,830.36-90,882.9
五、现金及现金等价物净增加额-77,681,836.15-38,943,982.06-57,139,168.28-27,851,754.05
  加:期初现金及现金等价物余额268,170,278.7268,170,278.7271,359,319.52296,022,032.75
  期末现金及现金等价物余额190,488,442.55229,226,296.64214,220,151.24268,170,278.7
补充资料:
  净利润-198,972,079.21-302,635,591.07
  资产减值准备--136,219.03-9,768,205.7
  固定资产和投资性房地产折旧-31,483,179.95-60,018,412.6
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-31,483,179.95-60,018,412.6
  无形资产摊销-7,973,614.01-16,616,901.38
  长期待摊费用摊销-4,526,786.27-7,815,810.21
  处置固定资产、无形资产和其他长期资产的损失----51,391,981.31
  固定资产报废损失-36,548.9-643,812.09
  财务费用-3,529,226.29-11,615,380.81
  投资损失--21,857,068.2--1,688,667.73
  递延所得税--612,812.19--2,590,015.73
  其中:递延所得税资产减少-898,412.57--1,119,216.66
    递延所得税负债增加--1,511,224.76--1,470,799.07
  存货的减少--17,704,497.52-32,289,097.86
  经营性应收项目的减少--21,552,982.43--62,708,250.21
  经营性应付项目的增加-81,579,312.42-57,791,029.41
  其他---175,229.28
  现金的期末余额-229,226,296.64-268,170,278.7
  减:现金的期初余额-268,170,278.7-296,022,032.75
  现金及现金等价物的净增加额--38,943,982.06--27,851,754.05
公告日期2026-10-292026-08-292026-04-252026-04-25
审计意见(境内)标准无保留意见
TOP↑